Puma Biotechnology | PBYI - Ebit





Ebit Perubahan Tanggal
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Exelixis USD 268.42M 20.01M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Glaxosmithkline GBP 2.15B 157M 2026-09
Incyte USD -707.47M 1.41B 2026-09
MacroGenics USD -65.25M 33.36M 2026-06
Moderna USD 130M 945M 2026-09
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Takeda JPY 205.32B 3.9B 2026-09
TG Therapeutics USD 85.9M 64.22M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09